Skip Navigation


Bioinformatics Advance Access originally published online on August 2, 2005
Bioinformatics 2005 21(19):3797-3800; doi:10.1093/bioinformatics/bti607
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (Print PDF) Freely available
Right arrowOA All Versions of this Article:
21/19/3797    most recent
bti607v1
Right arrow Comments: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (70)
Google Scholar
Right arrow Articles by de Oliveira, T.
Right arrow Articles by Vandamme, A.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Oliveira, T.
Right arrow Articles by Vandamme, A.-M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions{at}oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions{at}oxfordjournals.org

An automated genotyping system for analysis of HIV-1 and other microbial sequences

Tulio de Oliveira 1,*, Koen Deforche 2, Sharon Cassol 3, Mika Salminen 4, Dimitris Paraskevis 2, Chris Seebregts 5, Joe Snoeck 2, Estrelita Janse van Rensburg 3, Annemarie M. J. Wensing 6,7, David A. van de Vijver 6, Charles A. Boucher 6, Ricardo Camacho 8 and Anne-Mieke Vandamme 2

1Evolution Group at the Zoology Department, University of Oxford UK
2Rega Institute for Medical Research, Katholieke Universiteit Leuven Leuven, Belgium
3HIV-1 Immunopathogenesis and Therapeutics Research Program, Department of Medical Virology, University of Pretoria Pretoria, South Africa
4Department of Infectious Disease Epidemiology, HIV-Laboratory, National Public Health Institute Helsinki, Finland
5Research Information Systems Division, South African Medical Research Council Cape Town, South Africa
6Department of Medical Microbiology, Sub department of Virology and Eijkman Winkler Institute, University Medical Center Utrecht Utrecht, The Netherlands
7Division of Internal Medicine and Dermatology, Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht Utrecht, The Netherlands
8Virology Laboratory, Hospital Egas Moniz Lisbon, Portugal

*To whom correspondence should be addressed.

Motivation: Genetic analysis of HIV-1 is important not only for vaccine development, but also to guide treatment strategies, track the emergence of new viral variants and ensure that diagnostic assays are contemporary and fully optimized. However, most genotyping methods are laborious and complex, and involve the use of multiple software applications. Here, we describe the development of an automated genotyping system that can be easily applied to HIV-1 and other rapidly evolving viral pathogens.

Results: The new REGA subtyping tool, developed using Java programming and PERL scripts, combines phylogenetic analyses with bootscanning methods for the genetic subtyping of full-length and subgenomic fragments of HIV-1. When used to investigate the subtype of previously published reference datasets that were analysed using manual phylogenetic methods, the automated method correctly identified 97.5–100% of non-recombinant and circulating recombinant forms of HIV-1, including 108 full-length, 108 gag and 221 env sequences downloaded from the Los Alamos database.

Availability: The tool, which can be easily downloaded and installed on either a UNIX or Linux-based computer system, is available at http://www.bioafrica.net/subtypetool/html/

Contact: tulio.deoliveira{at}zoology.oxford.ac.uk

Received on March 28, 2005; revised on June 23, 2005; accepted on July 28, 2005

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
A. B. Abecasis, A.-M. Vandamme, and P. Lemey
Quantifying Differences in the Tempo of Human Immunodeficiency Virus Type 1 Subtype Evolution
J. Virol., December 15, 2009; 83(24): 12917 - 12924.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Low, N. Prada, M. Topper, F. Vaida, D. Castor, H. Mohri, D. Hazuda, M. Muesing, and M. Markowitz
Natural Polymorphisms of Human Immunodeficiency Virus Type 1 Integrase and Inherent Susceptibilities to a Panel of Integrase Inhibitors
Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4275 - 4282.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
K. Covens, N. Dekeersmaeker, Y. Schrooten, J. Weber, D. Schols, M. E. Quinones-Mateu, A.-M. Vandamme, and K. Van Laethem
Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs
J. Clin. Microbiol., July 1, 2009; 47(7): 2232 - 2242.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A.-K. Schultz, M. Zhang, I. Bulla, T. Leitner, B. Korber, B. Morgenstern, and M. Stanke
jpHMM: Improving the reliability of recombination prediction in HIV-1
Nucleic Acids Res., July 1, 2009; 37(suppl_2): W647 - W651.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. C. J. Alcantara, S. Cassol, P. Libin, K. Deforche, O. G. Pybus, M. Van Ranst, B. Galvao-Castro, A.-M. Vandamme, and T. de Oliveira
A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences
Nucleic Acids Res., July 1, 2009; 37(suppl_2): W634 - W642.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Hue, R. J. Gifford, D. Dunn, E. Fernhill, D. Pillay, and on Behalf of the UK Collaborative Group on HIV Dru
Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naive Individuals
J. Virol., March 15, 2009; 83(6): 2645 - 2654.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Waleria-Aleixo, A. N. Martins, M. B. Arruda, R. M. Brindeiro, R. M. Da-Silva, F. F. Nobre, D. B. Greco, and A. Tanuri
Drug Resistance Mutation Profile and Accumulation Kinetics in Human Immunodeficiency Virus-Positive Individuals Infected with Subtypes B and F Failing Highly Active Antiretroviral Therapy Are Influenced by Different Viral Codon Usage Patterns
Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4497 - 4502.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
P. Hraber, C. Kuiken, M. Waugh, S. Geer, W. J. Bruno, and T. Leitner
Classification of hepatitis C virus and human immunodeficiency virus-1 sequences with the branching index
J. Gen. Virol., September 1, 2008; 89(9): 2098 - 2107.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
K. Deforche, R. Camacho, K. Van Laethem, P. Lemey, A. Rambaut, Y. Moreau, and A.-M. Vandamme
Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment
Bioinformatics, January 1, 2008; 24(1): 34 - 41.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. J. Gifford, T. de Oliveira, A. Rambaut, O. G. Pybus, D. Dunn, A.-M. Vandamme, P. Kellam, D. Pillay, and on Behalf of the UK Collaborative Group on HIV Dru
Phylogenetic Surveillance of Viral Genetic Diversity and the Evolving Molecular Epidemiology of Human Immunodeficiency Virus Type 1
J. Virol., December 1, 2007; 81(23): 13050 - 13056.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. T. P. Gilbert, A. Rambaut, G. Wlasiuk, T. J. Spira, A. E. Pitchenik, and M. Worobey
From the Cover: The emergence of HIV/AIDS in the Americas and beyond
PNAS, November 20, 2007; 104(47): 18566 - 18570.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. B. Abecasis, P. Lemey, N. Vidal, T. de Oliveira, M. Peeters, R. Camacho, B. Shapiro, A. Rambaut, and A.-M. Vandamme
Recombination Confounds the Early Evolutionary History of Human Immunodeficiency Virus Type 1: Subtype G Is a Circulating Recombinant Form
J. Virol., August 15, 2007; 81(16): 8543 - 8551.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
X. Wu, Z. Cai, X.-F. Wan, T. Hoang, R. Goebel, and G. Lin
Nucleotide composition string selection in HIV-1 subtyping using whole genomes
Bioinformatics, July 15, 2007; 23(14): 1744 - 1752.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
L. Lu, C. Li, Y. Fu, F. Gao, O. G. Pybus, K. Abe, H. Okamoto, C. H. Hagedorn, and D. Murphy
Complete genomes of hepatitis C virus (HCV) subtypes 6c, 6l, 6o, 6p and 6q: completion of a full panel of genomes for HCV genotype 6
J. Gen. Virol., May 1, 2007; 88(5): 1519 - 1525.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. M. Rousseau, G. H. Learn, T. Bhattacharya, D. C. Nickle, D. Heckerman, S. Chetty, C. Brander, P. J. R. Goulder, B. D. Walker, P. Kiepiela, et al.
Extensive Intrasubtype Recombination in South African Human Immunodeficiency Virus Type 1 Subtype C Infections
J. Virol., May 1, 2007; 81(9): 4492 - 4500.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
K. Deforche, T. Silander, R. Camacho, Z . Grossman, M. A. Soares, K. Van Laethem, R. Kantor, Y. Moreau, A.-M. Vandamme, and on behalf of the non-B Workgroup
Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance
Bioinformatics, December 15, 2006; 22(24): 2975 - 2979.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Snoeck, R. Kantor, R. W. Shafer, K. Van Laethem, K. Deforche, A. P. Carvalho, B. Wynhoven, M. A. Soares, P. Cane, J. Clarke, et al.
Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 694 - 701.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.